Fig 1: Effect of CIA and EA treatment on ADA expression in synovial membranes. (a) (1)-(2), (3)-(4), and (5)-(6) show the immunostaining of ADA in synovial membranes in the sham-control, CIA-control, and CIA-EA groups, respectively. (b) Quantification of the immunostaining of sections of the synovial membrane. Each section was examined at high magnification. Results represent the mean of five different fields on each section. Data are expressed as mean ± SD. ∗ P < 0.01 versus the sham-control group; # P < 0.05 versus the CIA-control group. Magnification: ×100 (3), ×200 ((1) and (5)), and ×400 ((2), (4), and (6)).
Fig 2: Dissecting genetic underpinnings of epithelial proximalization following SBR. (A) RNA-FISH for Creb3l3 shows significant upregulation of transcripts (fluorescein signal) per nucleated cell (DAPI) at days 7 and 70 after surgery. Images are at 60×, scale bar = 30µm, acquired using Olympus FV1200 Confocal Microscope. Day 7: n = 15 sham images, n = 14 SBR images (3 biological replicates). Day 70: n = 9 sham images, n =10 SBR images (2 biological replicates). (B) Projection of Creb3l3 and Klf4 transcript enrichment onto the UMAP plot shows increased expression with enterocyte maturation. Color scale bar indicates relative intensity of gene expression. (C) Violin plots showing differential expression of Creb3l3 and Klf4 between sham and SBR. (D) The length down from the villus tip was measured for appreciably higher Creb3l3 (left, 3 sham and 3 SBR biological replicates) and ADA (right, 3 sham and 4 SBR biological replicates) expression, and represented as a percent of total villus length. Representative immunohistochemistry staining for ADA in sham and SBR mice at postoperative day 7 is shown. Images are at 20×, scale bar = 100 µm. (E) Relative Creb3l3 expression in SI from day 3 postoperative sham and SBR mice (n = 3 sham and n = 5 SBR mice) was measured using qPCR. (F) Interactome of genes upregulated in SBR epithelium. Genes in red are involved in RA signaling. All graphs are presented as mean ± SD. ns, not significant. *P < .05, **P < .01, ***P < .001, ****P < .0001.
Fig 3: Effect of CIA and EA treatment on CD73 and ADA mRNA expression in peripheral blood mononuclear cells. mRNA was quantified by qRT-PCR. Data (fold change) are expressed as mean ± SD. ∗ P < 0.01 versus the sham-control group. # P < 0.01 versus the CIA-control group.
Fig 4: Metabolism of adenosine. Acupuncture causes ATP release. ATP is metabolized extracellularly to AMP by ectonucleotidases. CD73 hydrolyzes AMP to adenosine. Finally, adenosine is degraded to inosine by ADA or transported back into cells.
Fig 5: Expression of EAD‐pathway enzymes on PMNs is altered with age. (a) Bone marrow cells were isolated from young and old C57BL/6 mice, and basal expression of EAD‐pathway components was assessed by flow cytometry. (b) Blood was collected from young and old C57BL/6 mice and expression of EAD‐pathway components was assessed by flow cytometry. (a, b) We gated on PMNs (Ly6G+CD11b+ cells) and measured the expression (mean fluorescent intensity or MFI) of CD73, CD39, ADA, A1R, A2AR, A2BR and A3R. (a) Data shown are pooled from three separate experiments (n = 3 mice per age group) with each condition tested in triplicate. (b) Data are pooled from four separate experiments with 7 mice per age group. *Significant differences from uninfected controls calculated by Student's t‐test
Supplier Page from Abcam for Anti-ADA antibody